Angina Pectoris Drugs Market By Drug Class (Beta Blockers, Calcium Channel Blockers, Nitrates, Antiplatelet Agents, ACE Inhibitors, Ranolazine), By Type of Angina (Stable Angina, Unstable Angina, Variant (Prinzmetal) Angina), By Route of Administration (Oral, Intravenous, Sublingual), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Mar 2025 | Report ID: MI2171 | 210 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Drug Class

  • Beta Blockers
  • Calcium Channel Blockers
  • Nitrates
  • Antiplatelet Agents
  • ACE Inhibitors
  • Ranolazine

By Type of Angina

  • Stable Angina
  • Unstable Angina
  • Variant (Prinzmetal) Angina

By Route of Administration

  • Oral
  • Intravenous
  • Sublingual

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • AstraZeneca
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing